CTEA.L Regulatory News (CTEA)

2 August 2021

Catenae Innovation PLC

("Catenae" or the "Company")

Collaboration agreement with ProMake Limited

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that it has signed a collaboration agreement with ProMake Limited ("ProMake"), a global specialist in material science and medical innovations. Under the terms of the agreement, Catenae will be the exclusive provider of data management services to ProMake to fulfil its position on the Public Health England ("PHE") National Microbiology Framework.

ProMake has unique intellectual property and technology that utilises graphene and other nano-materials within an injection moulded 'PreVent' tube, which a patient blows into in order to provide medical samples. The test may be used to diagnose many different diseases using a much less invasive method and at a potentially lower cost to conventional methods. Initially, the PreVent tube will be processed in a lab but ProMake's aim is to build an inexpensive 'Bio-Pod' device that will analyse the sample locally and pass data to a cloud based platform for diagnosis via an individual's mobile app.

The National Microbiology Framework, announced by PHE in November 2020, supports the newly formed UK Health Security Agency (UKHSA) and the Government's effort to provide a broad range of medical testing and diagnostic services for people in the UK. More information on the Framework can be found via this link: https://www.government-online.net/national-microbiology-framework-public-health-england/

Catenae forms part of a ProMake led consortium which has been awarded positions in Lot 2 (Research and Development Goods and Services) and Lot 4 (Clinical Laboratoty Diagnostic Testing Services) of the PHE Framework Agreement. Other consortium members include Haydale Graphene Industries plc (AIM:HAYD), the advanced materials group that will be the manufacturing and exclusive nano materials partner to the consortium. Haydale recently made the following announcement in relation to the ProMake led consortium, which can be found via this link: https://www.haydale-ir.com/content/news/archive/2021/120721

Catenae's role within the consortium will be to securely capture and process patient and test data, control access to that data in a compliant manner and provide reporting services through dashboards, mobile apps, web and blockchain technology. ProMake's intention is to automate all aspects of the supply chain from the manufacture, distribution and use of the Pre-Vent tubes through to their ultimate disposal. Catenae will manage the data throughout that supply chain and where appropriate make the data available to individuals and organisations.

Under this collaboration agreement, Catenae will also provide consulting services to support ProMake in its engagement with the organisations able to access the Framework Agreement, which includes:

· Public Health England;

· Department of Health and Social Care;

· Public Health Wales;

· Public Health Scotland;

· Department for Health for Northern Ireland;

· Health and Social Care Northern Ireland;

· NHS Authorities, NHS Trusts, NHS Foundation Trusts, Special Health Authorities, NHS Scotland Health Boards, NHS Wales Health Boards, NHS Northern Ireland Health Boards, Special NHS Boards and any other NHS entity;

· Local Authorities;

· Any other bodies governed by public law (as defined in regulation 2 of the Public Contracts Regulations 2015 (SI 2015/102) (as amended); and

· Academic or charitable institutions (including any such institutions that are not Contracting Authorities).

The Catenae Board considers that it is premature to provide any guidance as to the timing or value to Catenae of this collaboration, but anticipates being able to give a more detailed update in the coming months.

Guy Meyer, Chief Executive Officer of Catenae, said: "We are delighted to announce this collaboration agreement with ProMake to support its work within the Public Health England National Microbiology Framework. Our provision of data management services and support in Lots 2 and 4 of the framework demonstrates the digital transformational application of Catenae's innovative technologies, as well as the Company's continued commitment to delivering people centric technology solutions.

"Our data management services can be successfully applied to a number of sectors and industries, with Covid-19 testing and related services a continued area of work for Catenae."

Jason Laing, Co-Founder and CEO of ProMake, said: "On behalf of ProMake, I would like to thank Catenae for the support it has given us through this tender process. We are excited to work with Catenae and employ its data management services to fulfil our position on the National Microbiology Framework."

- Ends -

For further information please contact:

Notes to Editors:

About Catenae Innovation PLC

Catenae Innovation is an AIM quoted provider of digital media and technology services. Catenae use the power of blockchain to deliver solutions where its people-centric technology enables trust and certainty allowing organisations to gain better control over their operations, manage staff and safely welcome customers.

www.catenaeinnovation.com

About ProMake Limited

ProMake specialises in the design, development and manufacturing of medical innovations and devices. It engages in fabricating medical diagnostic and therapeutic apparatus, marketing & distribution.

www.promake.com

About Haydale

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials.

https://haydale.com